Gene · 4919
Papers2,258
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,258
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in PET/CT Imaging for Breast Cancer. | J Clin Med | 2023 | 37445572 | PubTator, text mining | PubMed |
| Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy. | Cancers (Basel) | 2023 | 37444586 | PubTator, text mining | PubMed |
| Vaccines in Breast Cancer: Challenges and Breakthroughs. | Diagnostics (Basel) | 2023 | 37443570 | PubTator, text mining | PubMed |
| Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression. | Cell Commun Signal | 2023 | 37430307 | PubTator, text mining | PubMed |
| MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. | Exp Mol Med | 2023 | 37430087 | PubTator, text mining | PubMed |
| Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. | Onco Targets Ther | 2023 | 37425981 | PubTator, text mining | PubMed |
| Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia. | J Hematol Oncol | 2023 | 37422670 | PubTator, text mining | PubMed |
| Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer. | Mol Cancer | 2023 | 37415164 | PubTator, text mining | PubMed |
| ROR1-STAT3 signaling contributes to ovarian cancer intra-tumor heterogeneity. | Cell Death Discov | 2023 | 37400436 | PubTator, text mining | PubMed |
| Wnt signaling: Essential roles in osteoblast differentiation, bone metabolism and therapeutic implications for bone and skeletal disorders. | Genes Dis | 2023 | 37397540 | PubTator, text mining | PubMed |
| Targeting PD-1/PD-L1 in cancer immunotherapy: An effective strategy for treatment of triple-negative breast cancer (TNBC) patients. | Genes Dis | 2023 | 37397537 | PubTator, text mining | PubMed |
| Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers. | Int J Mol Sci | 2023 | 37373521 | PubTator, text mining | PubMed |
| Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells. | Int J Mol Sci | 2023 | 37373343 | PubTator, text mining | PubMed |
| Exosomes as Novel Diagnostic Biomarkers and Therapeutic Tools in Gliomas. | Int J Mol Sci | 2023 | 37373314 | PubTator, text mining | PubMed |
| [Current researches and progresses on new antibody drugs in the treatment of relapsed/refractory diffuse large B-cell lymphoma]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37356992 | PubTator, text mining | PubMed |
| [Chinese consensus on minimal residual disease detection and interpretation of patients with chronic lymphocytic leukemia (2023)]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37356978 | PubTator, text mining | PubMed |
| The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer. | Oncol Ther | 2023 | 37354381 | PubTator, text mining | PubMed |
| MTX-13, a Novel PTK7-Directed Antibody-Drug Conjugate with Widened Therapeutic Index Shows Sustained Tumor Regressions for a Broader Spectrum of PTK7-Positive Tumors. | Mol Cancer Ther | 2023 | 37352387 | PubTator, text mining | PubMed |
| GNL3 and PA2G4 as Prognostic Biomarkers in Prostate Cancer. | Cancers (Basel) | 2023 | 37345060 | PubTator, text mining | PubMed |
| ROR1/STAT3 positive feedback loop facilitates cartilage degeneration in Osteoarthritis through activation of NF-κB signaling pathway. | Int Immunopharmacol | 2023 | 37343369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4919/papers?page=18